Neuren Pharmaceuticals financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2004 2022 2023 2024
Rev. Revenue
$2.17M $1.49M $1.07M $2.72M $6.18M $6.12M $4.15M $5.33M $4.79M $2.93M $1.67M $3.15M $0.63M $13.99M $0.50M $0.72M $3.20M $2.59M $15.42M $231.94M $0.00M
GM % Gross Margin %
-289.19% 0.00% 0.00% 0.00% 27.46% -57.50% -73.35% -54.32% -80.50% -241.73% 0.00% 0.00% 0.00% 56.39% 0.00% 0.00% -197.65% -153.48% 17.55% 88.47% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% -1.05% -103.23% -161.37% -124.10% -138.01% 0.00% 0.00% 0.00% 0.00% 41.57% 0.00% 0.00% -257.52% -233.89% -4.75% 85.90% 0.00%
EPS Earnings Per Share
$-0.13 $-0.10 $-0.16 $-0.12 $-0.01 $0.07 $-0.11 $-0.09 $-0.07 $0.00 $1.20 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.00% 0
Sha. Shares
5m 5.6m 6.56m 12.87m 17.61m 21.24m 57.79m 59.14m 74.66m 79.76m 85.85m 92.1m 101.84m 100.17m 100.17m 114.61m 114.61m 0m 125.97m 127.27m 127.35m
OCF Operating Cash Flow
$-8.99M $-10.25M $-13.06M $-10.81M $-1.59M $-3.79M $-4.11M $-3.72M $-7.11M $-6.41M $-12.73M $-12.38M $-5.59M $6.41M $-11.72M $-8.08M $-9.97M $-3.99M $3.60M $184.93M $0.00M
FCF Free Cash Flow
$-9.04M $-10.48M $-13.22M $-10.84M $-1.60M $-3.80M $0.00M $-3.76M $-7.78M $-6.44M $-12.73M $-12.39M $-5.59M $6.41M $-11.73M $-8.08M $-9.98M $-4.01M $3.58M $175.35M $0.00M
FCFS Free Cash Flow Per Share
$-1.84 $-1.80 $-1.98 $-0.97 $-0.12 $-0.20 $-0.11 $-0.06 $-0.11 $-0.08 $-0.15 $-0.15 $-0.06 $0.06 $-0.12 $-0.08 $-0.08 $-1.99 $0.03 $1.45 $0.00